Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health
CARES-REACH
1 other identifier
observational
49
1 country
1
Brief Summary
This study is to assess the impact of the CARES-REACH intervention on colorectal cancer screening rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 25, 2020
CompletedFirst Submitted
Initial submission to the registry
July 2, 2020
CompletedFirst Posted
Study publicly available on registry
July 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 26, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
December 3, 2025
December 1, 2025
7.3 years
July 2, 2020
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Colorectal Cancer Screening Rates - Initial FIT
Percentage of patients who complete initial Fecal Immunochemical Test (FIT)
Years 1-5
Change in Colorectal Cancer Screening Rates - Repeat FIT
Percentage of patients who complete a repeat Fecal Immunochemical Test (FIT)
Years 1-5
Secondary Outcomes (1)
Differences in Screening Rates
Years 2-5
Study Arms (3)
Wave 1 Only: Clinics using CARES Intervention
Based on a stratified (rural vs urban) procedure, investigators will randomly select 7 clinics to implement the Colorectal Cancer Awareness, Research, Education \& Screening (CARES) intervention.
Wave 1 Only: Control Clinics
Based on a stratified (rural vs urban) procedure, investigators will randomly select 7 clinics as control (usual care) clinics.
All Clinics
For Wave 2, the 7 clinics in the control group will roll out as intervention clinic, thus, all 14 clinics will be exposed to the intervention by year 2.
Interventions
Providers will be trained to use Electronic Medical Record (EMR) tools and prompts, and an organization wide cancer control champion will be trained to motivate providers and navigate patients.
Remote/electronic data collection surveys will be conducted with clinic institution leaders, cancer control champions, and providers from various clinic locations to solicit feedback about implementation processes at three time points (baseline, mid-point and end of study implementation)
Eligibility Criteria
Staff and providers from the two participating Federally Qualified Health Care systems - Central Florida Health Centers and Manatee County Rural Health Services.
You may qualify if:
- Staff and providers working in a clinic within one of the two participating systems
- Involved in adult patient care
You may not qualify if:
- Staff and providers who are not engaged in directing or decisions related to colo-rectal cancer screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Related Publications (2)
Montoya SM, Olaore P, Bastardo-Acosta J, Abdulla R, Schell MJ, Hidalgo A, Turner B, Rider M, Kishun-Jit N, Pollard J, Friedman M, Byrne MM, Christy SM, Meade CD, Gwede CK. Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center Clinics: A stepped-wedge, multilevel intervention trial. Contemp Clin Trials. 2026 Mar 2:108274. doi: 10.1016/j.cct.2026.108274. Online ahead of print.
PMID: 41780746DERIVEDMontoya SM, Olaore P, Bastardo-Acosta J, Abdulla R, Schell MJ, Hidalgo A, Turner B, Rider M, Kishun-Jit N, Joshua A, Pollard J, Friedman M, Christy SM, Meade CD, Gwede CK. Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center clinics: A stepped-wedge, multilevel intervention trial. Res Sq [Preprint]. 2024 Jul 18:rs.3.rs-4558718. doi: 10.21203/rs.3.rs-4558718/v1.
PMID: 39070625DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clement K Gwede, PhD MPH RN FAAN
Moffitt Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2020
First Posted
July 9, 2020
Study Start
June 25, 2020
Primary Completion (Estimated)
October 26, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
December 3, 2025
Record last verified: 2025-12